(0.51%) 5 214.08 points
(0.85%) 39 388 points
(0.27%) 16 346 points
(0.75%) $79.58
(5.53%) $2.31
(1.27%) $2 351.70
(3.47%) $28.56
(0.85%) $992.95
(-0.29%) $0.927
(-0.41%) $10.85
(-0.22%) $0.798
(0.88%) $92.55
Quarter results today
(bmo 2024-05-09)
Expected move: +/- 11.91%
-3.63% $ 4.78
@ $4.41
Emitido: 14 feb 2024 @ 15:08
Retorno: 8.39%
Señal anterior: feb 14 - 14:15
Señal anterior:
Retorno: -0.23 %
Live Chart Being Loaded With Signals
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America...
Stats | |
---|---|
Volumen de hoy | 2.08M |
Volumen promedio | 2.28M |
Capitalización de mercado | 3.36B |
EPS | $0 ( 2024-05-01 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 12.58 |
ATR14 | $0.0120 (0.25%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-11 | Ronaghi Mostafa | Buy | 25 315 | Stock Option (right to buy) |
2024-04-11 | Ronaghi Mostafa | Buy | 200 000 | Stock Option (right to buy) |
2024-04-11 | Ronaghi Mostafa | Buy | 0 | |
2024-04-02 | Soni Manmeet Singh | Buy | 1 100 000 | Stock Option (right to buy) |
2024-04-02 | Anand Bhaskar | Buy | 600 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
99.43 |
Last 89 transactions |
Buy: 581 405 260 | Sell: 937 995 |
Volumen Correlación
Summit Therapeutics plc Correlación
10 Correlaciones Más Positivas | |
---|---|
ACST | 0.898 |
TATT | 0.892 |
NPCE | 0.892 |
DRTT | 0.89 |
VSTM | 0.884 |
AVIR | 0.881 |
GLMD | 0.881 |
MREO | 0.879 |
CNXC | 0.872 |
SRPT | 0.87 |
10 Correlaciones Más Negativas | |
---|---|
MTEK | -0.922 |
BFRI | -0.905 |
CINC | -0.873 |
SNCR | -0.868 |
MLVF | -0.862 |
SLDP | -0.858 |
LEDS | -0.858 |
PPBT | -0.858 |
XPDI | -0.856 |
PMD | -0.852 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Summit Therapeutics plc Correlación - Moneda/Commodity
Summit Therapeutics plc Finanzas
Annual | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-2.05M (0.00 %) |
EPS: | $-0.990 |
FY | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-2.05M (0.00 %) |
EPS: | $-0.990 |
FY | 2022 |
Ingresos: | $704 295 |
Beneficio Bruto: | $-1.81M (-256.95 %) |
EPS: | $-0.380 |
FY | 2021 |
Ingresos: | $1 809.00 |
Beneficio Bruto: | $1 809.00 (100.00 %) |
EPS: | $-0.000960 |
Financial Reports:
No articles found.
Summit Therapeutics plc
Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. It also offers SMT-738, for combating multidrug resistant infections primarily carbapenem-resistant Enterobacteriaceae infections; and DDS-04 series for the potential treatment of infections caused by the Enterobacteriaceae. The company was founded in 2003 and is based in Cambridge, Massachusetts.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico